Published 2022 | Version v1
Publication Metadata-only

In-vivo treatment with the GPR17 antagonist montelukast ameliorated the lifespan and delayed the disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis

Nhung Nguyen
M. Milanese
S. Raffaele
R. A. Zerbo
M. Fumagalli
M. P. Abbracchio
G. Bonanno
T. Bonifacino
Others:
Nguyen, Nhung
Milanese, M.
Raffaele, S.
Zerbo, R. A.
Fumagalli, M.
Abbracchio, M. P.
Bonanno, G.
Bonifacino, T.

Additional details

Identifiers Origin repository
Created:
February 13, 2024
Modified:
February 13, 2024